Nectero Medical, Inc.
Clinical trials sponsored by Nectero Medical, Inc., explained in plain language.
-
New one-time procedure aims to prevent deadly aneurysm ruptures
Disease control Recruiting nowThis study tests a single-dose treatment delivered through a catheter to stabilize small to mid-sized abdominal aortic aneurysms (AAA) in 400 adults aged 21-85. The treatment is compared to standard monitoring. The goal is to prevent AAA-related death, rupture, or need for surger…
Phase: PHASE2, PHASE3 • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
Second chance: new device retreatment for bulging aorta
Disease control Recruiting nowThis study tests whether giving a second treatment with the Nectero EAST system is safe and helps slow the growth of abdominal aortic aneurysms (a bulging blood vessel in the belly). Ten adults who already had one treatment will receive another dose. Doctors will check for side e…
Phase: NA • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated May 18, 2026 11:58 UTC